Literature DB >> 16869908

Transformation of Acinetobacter sp. BD413 with DNA from commercially available genetically modified potato and papaya.

M Iwaki1, Y Arakawa.   

Abstract

AIM: To estimate the likelihood of transfer of kanamycin-resistance gene (nptII) from commercially available genetically modified (GM) plants. METHODS AND
RESULTS: Acinetobacter sp. BD413 carrying a plasmid containing an inactivated nptII gene was treated with DNA derived from GM potato and GM papaya. Kanamycin-resistant transformants were obtained at a frequency of 10-30 microg(-1) DNA. Calculation of the results suggested that 6-9 x 10(4) molecules of genomic DNA from GM plants were needed to obtain one transformant. However, such transformation events were not detectable in the absence of the plasmid in the host strain.
CONCLUSIONS: Acinetobacter sp. BD413 was transformed with DNA derived from GM potato and GM papaya, in the presence of an inactivated nptII gene on a plasmid. However, the frequency of such events in the natural environment on wild-type strains, while evidently low, remains unknown. SIGNIFICANCE AND IMPACT OF THE STUDY: Our results may help to evaluate potential risks associated with the use of antibiotic-resistance determinants as genetic markers in GM plants. Complete risk assessment must consider factors other than transformation frequency alone, including the natural background of antibiotic resistance present in bacterial populations, and the spectrum and clinical use of the antimicrobial agents in question.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16869908     DOI: 10.1111/j.1472-765X.2006.01924.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  1 in total

1.  Exploring the evolutionary dynamics of plasmids: the Acinetobacter pan-plasmidome.

Authors:  Marco Fondi; Giovanni Bacci; Matteo Brilli; Maria Cristiana Papaleo; Alessio Mengoni; Mario Vaneechoutte; Lenie Dijkshoorn; Renato Fani
Journal:  BMC Evol Biol       Date:  2010-02-24       Impact factor: 3.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.